CID 169494480

Gpr183 antagonist-2

Structural Information

Molecular Formula
C20H18F2N4O5
SMILES
COC1=NC=C(C=N1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC4=C(C=C3)OC(O4)(F)F
InChI
InChI=1S/C20H18F2N4O5/c1-29-19-23-11-14(12-24-19)18(28)26-8-6-25(7-9-26)17(27)5-3-13-2-4-15-16(10-13)31-20(21,22)30-15/h2-5,10-12H,6-9H2,1H3/b5-3+
InChIKey
VLODLHKKDGGSJO-HWKANZROSA-N
Compound name
(E)-3-(2,2-difluoro-1,3-benzodioxol-5-yl)-1-[4-(2-methoxypyrimidine-5-carbonyl)piperazin-1-yl]prop-2-en-1-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

4
Patents

432.1245 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 433.13178 200.0
[M+Na]+ 455.11372 207.2
[M-H]- 431.11722 203.7
[M+NH4]+ 450.15832 205.2
[M+K]+ 471.08766 204.5
[M+H-H2O]+ 415.12176 186.9
[M+HCOO]- 477.12270 208.3
[M+CH3COO]- 491.13835 207.0
[M+Na-2H]- 453.09917 198.8
[M]+ 432.12395 198.9
[M]- 432.12505 198.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe